CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$527.115

Market cap

$7.88B

P/E Ratio

31.53

Dividend/share

$1.5

EPS

$16.72

Enterprise value

$7.94B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
Chemed's quick ratio has soared by 67% from the previous quarter and by 29% YoY
The debt is down by 45% since the previous quarter and by 39% year-on-year
The price to earnings (P/E) is 14% higher than the last 4 quarters average of 27.6 and 13% higher than the 5-year quarterly average of 27.8
The net income has declined by 7% year-on-year and by 4.8% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com
Peers: AMED SXT BCPC

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
14.95M
Market cap
$7.88B
Enterprise value
$7.94B
Valuations
Price to earnings (P/E)
31.53
Price to book (P/B)
9.81
Price to sales (P/S)
3.69
EV/EBIT
23.76
EV/EBITDA
20.19
EV/Sales
3.72
Earnings
Revenue
$2.13B
EBIT
$334.26M
EBITDA
$393.44M
Free cash flow
$254.89M
Per share
EPS
$16.72
Free cash flow per share
$17.07
Book value per share
$53.71
Revenue per share
$143.01
TBVPS
$50.97
Balance sheet
Total assets
$1.44B
Total liabilities
$643.3M
Debt
$136.5M
Equity
$798.72M
Working capital
-$24.59M
Liquidity
Debt to equity
0.17
Current ratio
0.92
Quick ratio
0.72
Net debt/EBITDA
0.16
Margins
EBITDA margin
18.4%
Gross margin
35.8%
Net margin
11.7%
Operating margin
16.1%
Efficiency
Return on assets
18.4%
Return on equity
34.8%
Return on invested capital
57.5%
Return on capital employed
29.2%
Return on sales
15.7%
Dividend
Dividend yield
0.28%
DPS
$1.5
Payout ratio
9%

CHE stock price

How has the Chemed stock price performed over time
Intraday
0.19%
1 week
2.14%
1 month
2.78%
1 year
8.57%
YTD
3.27%
QTD
3.27%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.13B
Gross profit
$765.09M
Operating income
$343.5M
Net income
$249.62M
Gross margin
35.8%
Net margin
11.7%
The net margin is down by 7% year-on-year and by 4.9% since the previous quarter
The net income has declined by 7% year-on-year and by 4.8% since the previous quarter
The operating margin has decreased by 4.7% QoQ
Chemed's operating income has decreased by 4.6% from the previous quarter

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
31.53
P/B
9.81
P/S
3.69
EV/EBIT
23.76
EV/EBITDA
20.19
EV/Sales
3.72
The price to earnings (P/E) is 14% higher than the last 4 quarters average of 27.6 and 13% higher than the 5-year quarterly average of 27.8
The EPS has decreased by 4% from the previous quarter and by 2.5% YoY
Chemed's equity has increased by 28% YoY and by 11% from the previous quarter
The P/B is 3.2% more than the 5-year quarterly average of 9.5 but 2% less than the last 4 quarters average of 10.0
CHE's P/S is 12% above its 5-year quarterly average of 3.3 and 8% above its last 4 quarters average of 3.4

Efficiency

How efficient is Chemed business performance
The company's return on invested capital fell by 24% YoY and by 2.9% QoQ
The ROE has contracted by 11% from the previous quarter but it has grown by 3.9% YoY
The ROA has declined by 7% since the previous quarter and by 6% year-on-year
The ROS has decreased by 4.8% YoY and by 3.7% from the previous quarter

Dividends

What is CHE's dividend history
Dividend details
DPS
$1.5
Dividend yield
0.28%
Payout ratio
9%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 124% higher than its total liabilities
Chemed's quick ratio has soared by 67% from the previous quarter and by 29% YoY
CHE's current ratio is up by 37% from the previous quarter and by 21% YoY
The debt is 83% smaller than the equity
CHE's debt to equity has dropped by 53% year-on-year and by 50% since the previous quarter
The debt is down by 45% since the previous quarter and by 39% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.